Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
US Department of Justice
Chinese Patent Office
Johnson and Johnson
UBS
Fish and Richardson
Harvard Business School
Covington
Argus Health

Generated: January 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Lucitanib

« Back to Dashboard

US Patents for Lucitanib

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Lucitanib ➤ Try a Free Trial Spiro substituted compounds as angiogenesis inhibitors Advenchen Laboratories, LLC (Northridge, CA) ➤ Try a Free Trial
Lucitanib ➤ Try a Free Trial Spiro substituted compounds as angiogenesis inhibitors Advenchen Laboratories, LLC (Moorpark, CA) ➤ Try a Free Trial
Lucitanib ➤ Try a Free Trial Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-- naphthamide and synthetic intermediates thereof EOS Ethical Oncology S.p.A. Abbreviated Form EOS S.p.A. (Milan, IT) ➤ Try a Free Trial
Lucitanib ➤ Try a Free Trial Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-- naphthamide and synthetic intermediates thereof Clovis Oncology Italy S.R.L. (Milan, IT) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Lucitanib

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Lucitanib Australia 2008226667 2027-03-14 ➤ Try a Free Trial
Lucitanib Brazil PI0808764 2027-03-14 ➤ Try a Free Trial
Lucitanib Canada 2681005 2027-03-14 ➤ Try a Free Trial
Lucitanib China 101558055 2027-03-14 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Citi
Johnson and Johnson
Healthtrust
AstraZeneca
Daiichi Sankyo
Mallinckrodt
Teva
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: